The problem of fibrosis in sarcoidosis

A. Wells (London, United Kingdom)

Source: Virtual Congress 2021 – Russian programme 2021
Session: Russian programme 2021
Session type: Language session
Number: 2654

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Wells (London, United Kingdom). The problem of fibrosis in sarcoidosis. Virtual Congress 2021 – Russian programme 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The pathomechanism of lung fibrosis and sarcoidosis
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016



The pathomechanism of lung fibrosis and sarcoidosis
Source: International Congress 2015 – PG17 Lung fibrosis and sarcoidosis
Year: 2015




Pathogenesis of pulmonary fibrosis in sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


Rare pneumoconioses
Source: Annual Congress 2005 - Update on orphan lung diseases
Year: 2005

Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
Source: Eur Respir Rev, 28 (153) 190044; 10.1183/16000617.0044-2019
Year: 2019



Cystic fibrosis fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


Extrapulmonary manifestations of cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 219-235
Year: 2014


The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013

Idiopathic pulmonary fibrosis (IPF): the patient journey
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Acute exacerbation in combined pulmonary fibrosis and emphysema (CPFE): what special features?
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020




Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018
Year: 2018



Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Non-pulmonary comorbidities in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Towards a better diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 108-113
Year: 2011



Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Pneumonia-like sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 233s
Year: 2003